Research Study

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Mongersen GED-0301 Maintenance Therapy in Subjects With Crohn's Disease
Principal Investigator 
Baljinder Salh

Overview

Body Locations and Systems 
Crohn's Disease
ClinicalTrials.gov# 
NCT02641392
Status 
Recruiting
Study Start/End 
Apr 24, 2017 to Apr 30, 2021
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Jo-Ann Ford, Research Coordinator
Phone 
604-875-5705
Purpose of Study 

The study is to evaluate the long-term safety of oral GED-0301 (mongersen) in subjects with Crohn's Disease.

 

 

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.